临床实验室在多囊卵巢综合征研究中角色的转变
The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome.
作者信息
Wallace A Michael, Sattar Naveed
机构信息
Department of Clinical Biochemistry and Vascular Biochemistry, Glasgow Royal Infirmary, Glasgow, UK.
出版信息
Clin Biochem Rev. 2007 Aug;28(3):79-92.
Abstract
In this review we outline clinical features, presentation and pathogenesis of polycystic ovarian syndrome (PCOS), treatment objectives and therapeutic options. We focus on and outline the changing role of the clinical laboratory in diagnosis and treatment of this condition. We also review recent information on the involvement of insulin resistance in the syndrome. We provide some explanation for confusion over the selection of the best hormone measurements for diagnosis. Finally, we outline the best current and future laboratory support for this common condition in young women.
摘要
在本综述中，我们概述了多囊卵巢综合征（PCOS）的临床特征、表现及发病机制、治疗目标和治疗选择。我们重点关注并概述了临床实验室在该疾病诊断和治疗中不断变化的作用。我们还回顾了有关胰岛素抵抗在该综合征中作用的最新信息。我们对诊断时最佳激素检测项目选择方面的困惑做出了一些解释。最后，我们概述了目前针对年轻女性这一常见疾病所能提供的最佳实验室支持以及未来的相关支持。
相似文献
1
The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome.
Clin Biochem Rev. 2007 Aug;28(3):79-92.
2
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
3
Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
Clin Endocrinol (Oxf). 2017 Oct;87(4):375-380. doi: 10.1111/cen.13380. Epub 2017 Jun 19.
4
New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
Obstet Gynecol Surv. 2002 Nov;57(11):755-67. doi: 10.1097/00006254-200211000-00022.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2.
6
DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS).
Technol Health Care. 2021;29(S1):11-25. doi: 10.3233/THC-218002.
7
Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Metabolism. 2021 Jun;119:154749. doi: 10.1016/j.metabol.2021.154749. Epub 2021 Mar 12.
8
Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
J Ethnopharmacol. 2020 Mar 25;250:111965. doi: 10.1016/j.jep.2019.111965. Epub 2019 Jun 8.
9
The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs).
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:32-5. doi: 10.1016/j.ejogrb.2014.05.006. Epub 2014 May 20.
10
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Hum Reprod. 2017 Aug 1;32(8):1723-1731. doi: 10.1093/humrep/dex226.
引用本文的文献
1
Gonadotropins in Keratoconus: The Unexpected Suspects.
Cells. 2019 Nov 22;8(12):1494. doi: 10.3390/cells8121494.
2
Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia.
Int J Fertil Steril. 2016 Apr-Jun;10(1):36-41. doi: 10.22074/ijfs.2016.4766. Epub 2016 Apr 5.
本文引用的文献
1
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.
N Engl J Med. 2007 Feb 8;356(6):551-66. doi: 10.1056/NEJMoa063971.
2
Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome.
Fertil Steril. 2006 Oct;86(4):934-41. doi: 10.1016/j.fertnstert.2006.02.108.
3
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
J Clin Endocrinol Metab. 2006 Nov;91(11):4205-14. doi: 10.1210/jc.2006-1645. Epub 2006 Aug 15.
4
Steroidogenic alterations and adrenal androgen excess in PCOS.
Steroids. 2006 Sep;71(9):751-9. doi: 10.1016/j.steroids.2006.05.005. Epub 2006 Jun 16.
5
Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
Clin Endocrinol (Oxf). 2006 Jun;64(6):603-10. doi: 10.1111/j.1365-2265.2006.02533.x.
6
Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone.
Ann Clin Biochem. 2006 May;43(Pt 3):196-9. doi: 10.1258/000456306776865034.
7
Investigation into possible causes of interference in serum testosterone measurement in women.
Ann Clin Biochem. 2006 May;43(Pt 3):189-95. doi: 10.1258/000456306776865106.
8
Anti-Müllerian hormone: a new marker for ovarian function.
Reproduction. 2006 Jan;131(1):1-9. doi: 10.1530/rep.1.00529.
9
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
Heart. 2005 Dec;91 Suppl 5(Suppl 5):v1-52. doi: 10.1136/hrt.2005.079988.
10
Guidance for the management of hirsutism.
Curr Med Res Opin. 2005 Aug;21(8):1227-34. doi: 10.1185/030079905X56475.
Zotero 插件